INTRODUCTION
============

In the yeast *Saccharomyces cerevisiae*, the reactions and enzyme-encoding genes of several metabolic pathways, like the sulfur and phospholipid pathways studied here, have been identified and partially characterized. Studies of synthetic interactions between genes have sought to identify higher-order, indirect interactions between biological pathways ([@B59]). Data from these studies have enabled the creation of quantitative models that integrate yeast metabolism and transcriptional regulation ([@B18]). However, our understanding of the yeast cell is still incomplete, as exemplified by the fact that no existing model is able to perfectly predict the in vivo response of a cell to external stimuli or genetic perturbations ([@B64]). One possible reason for this failure is that many genes have multiple cellular roles and participate in indirect or condition-specific genetic interactions that are difficult to identify and understand mechanistically. Likewise, many metabolites participate in multiple reactions, leading to complex connections between metabolic pathways.

One example is the sulfur assimilation pathway, which is a critical and ancient pathway present in all microbes and eukaryotes. This pathway incorporates extracellular sulfate into several key sulfur-containing compounds, including methionine, cysteine, homocysteine, and *S*-adenosylmethionine (SAM). The activity of this pathway has widespread influence on other cellular pathways, largely because SAM is required for most methyl transfer reactions ([@B58]). Accordingly, the biosynthetic genes of the sulfur assimilation pathway are controlled by a complex regulatory system that maintains the sulfur-containing compounds at appropriate levels ([@B27]). At the center of this regulatory system is the transcriptional activator Met4p, which is recruited to specific promoters by the site-specific DNA-binding cofactors Met31, Met32, and Cbf1 ([@B58]; [@B27]).

Transcriptional regulation occurs primarily at the level of Met4p activity, which is negatively regulated by SAM ([@B56]; [@B26]), creating a negative feedback loop that decreases sulfur assimilation when its products are sufficiently abundant. When SAM is abundant, Met4p is ubiquitinated, which, depending on other conditions, either leads to Met4p degradation by the proteasome or a change in Met4p activity ([@B21]; [@B44]; [@B25]; [@B14]; [@B10]). Besides controlling methionine metabolism, Met4p, when artificially overexpressed, causes a G~1~-S arrest, suggesting that Met4p mediates a cell cycle checkpoint ensuring that cells contain sufficient levels of metabolites before embarking toward cell division ([@B41]).

In this study, we found that the sulfur assimilation pathway genetically interacts with another metabolic pathway, the phospholipid biosynthesis pathway. Phospholipids, such as phosphatidylcholine (PC), make up a large fraction of membrane bilayers. The enzymatic genes of this pathway are repressed by Opi1p, a protein that directly senses the levels of phosphatidic acid (PA), a precursor of phospholipid biosynthesis. When the levels of PA are low because PA has been consumed by phospholipid biosynthesis, Opi1p represses transcription by inhibiting, through an unknown mechanism, the DNA-binding transcriptional activators Ino2p and Ino4p ([@B62]; [@B46]; [@B29]; [@B20]). Of interest, there is a metabolic connection between sulfur assimilation and phospholipid biosynthesis; PC is biosynthesized de novo from another phospholipid, phosphatidylethanolamine, in three steps that require SAM, formed by the sulfur assimilation pathway ([@B12]).

Deleting *MET4* results in methionine auxotrophy ([@B35]) because Met4p is required for the expression of many of the biosynthetic *MET* genes ([@B27]). Although there is no doubt that Met4p is required for methionine biosynthesis, there is conflicting evidence (described in [Table 1](#T1){ref-type="table"}) about whether Met4p is required for growth in the presence of exogenous methionine. Here we found that a *met4Δ* strain does indeed have a severe growth defect, suggesting that Met4p has a function in addition to regulating *MET* genes. Furthermore, we found that suppressors of the growth defect of a *met4Δ* strain arise very frequently. To understand how *met4Δ* growth is impaired, we used genome-wide tiling arrays, sequencing, and standard genetic analysis to characterize the suppressor mutations. We found that the suppression was most often caused by loss-of-function mutations in *OPI1*. Expression microarray studies using a Met4p-degradation system showed that Met4p activates genes involved in producing SAM, whereas Opi1p represses some of these genes in addition to genes whose products catalyze methyltransferase reactions of phospholipid biosynthesis. These results suggested that a *met4Δ* cell does not produce sufficient SAM for growth and a subsequent *opi1* mutation stimulates SAM production. Indeed, we found that adding SAM to the media or overexpressing the SAM synthetase gene allowed *met4Δ* cells to grow like wild-type cells. These results suggest that coordinated expression of the sulfur and phospholipid pathways contributes to optimal growth by ensuring that cells can maintain the considerable requirement for methylation in the biosynthesis of cell membrane phospholipids.

###### 

Strain backgrounds and phenotypes of *met4Δ* alleles.

  Strain background   *met4Δ* growth phenotype^a^   Reference
  ------------------- ----------------------------- -----------
  S288C               --                            [@B39]
  S288C               --                            [@B13]^b^
  S288C               Inviable                      [@B15]
  S288C               Slow-growing                  [@B49]
  W303                --                            [@B41]
  W303                --                            [@B1]^c^
  W303                --                            [@B28]^d^
  W303                --                            [@B27]^d^
  BF264-15D           --                            [@B21]^e^
  CY4                 --                            [@B61]^f^
  4094-B              --                            [@B35]^g^

^a^Phenotypes in the presence of exogenous methionine. --,no phenotype besides methionine auxotrophy.

^b^Strains in this study are made from the YPH98 strain, derived from YNN216, which is "congenic with S288C" ([@B48]).

^c^This study used a *met4Δ* strain in the W303 background that was created and used in earlier studies ([@B55]; [@B24]).

^d^This study used a *met4Δ* strain in the W303 background that was created in an earlier study ([@B44]).

^e^This study used the BF264-15D strain from Bruce Futcher ([@B43]).

^f^This study used the CY4 strain first mentioned in a previous study ([@B16]).

^g^This study used a methionine auxotroph that was isolated by UV mutagenesis. The identity of the mutation is not known.

RESULTS
=======

Met4p is required for normal growth, even in the presence of excess exogenous methionine
----------------------------------------------------------------------------------------

A *met4Δ* strain is a methionine auxotroph ([@B35]) but has been reported to have varying phenotypes in rich media, such as yeast extract/peptone/dextrose (YPD), that contain the exogenous methionine required for growth ([Table 1](#T1){ref-type="table"}). We noticed that fresh *met4Δ* haploid transformants formed very small colonies on YPD plates, even when provided with additional methionine. This phenotype was unstable: plating after overnight growth in YPD produced a mixture of small and large colonies. We decided to investigate this phenomenon by transforming a *met4Δ* allele into a diploid strain. The *met4Δ*/*MET4* heterozygous diploid formed large colonies, similar to wild type, suggesting that a cell with one copy of *MET4* is not haploinsufficient. To test more rigorously the growth phenotype of *met4Δ* haploids, we sporulated this diploid and followed growth of the haploid spore colonies on YPD plates ([Figure 1A](#F1){ref-type="fig"}). The *MET4* wild-type haploid grew as expected, but there was no *met4Δ* growth until day 3, suggesting that *MET4* is not absolutely essential for growth but is required for the optimal rate of growth. This growth defect always segregated 2:2 with the *met4Δ* allele, indicating that it was caused by loss of *MET4*.

![Deleting *MET4* causes slow growth, and this slow growth is spontaneously suppressed. (A) A *met4Δ* haploid grows poorly compared with *MET4*. A *met4Δ*/*MET4* heterozygote (DBY12042) was sporulated, and the resulting tetrads were dissected on YPD plates. To show that the growth defect was not a simply a germination defect and persisted over many divisions, the spore colonies were restreaked onto fresh YPD plates and grown for 2 d (bottom). A *MET4* wild type (FY4) is used as a control. Restreaking multiple times had the same effect. (B) The genomic locus surrounding the *MET4* ORF (denoted by a box), showing that expression of the essential *POL1* gene may be affected by deleting the *MET4* ORF. (C) The *met4Δ* growth defect can be rescued by a plasmid containing *MET4*. A *met4Δ*/*MET4* heterozygote containing either a *MET4* plasmid (DBY12210, right) or a control plasmid (DBY12211, left) was sporulated, and the resulting tetrads were dissected on YPD plates. (D) When *met4Δ* haploid cells (DBY12213) are grown overnight in liquid rich medium, fast-growing cells arise in the population. This was repeated with *met4Δ* cells from ∼30 independent tetrads generated by sporulation of a *met4Δ*/*MET4* heterozygote, with very similar results.](4192fig1){#F1}

We initially tested three obvious explanations for *met4Δ* slow growth and found that none of them accounted for the phenotype. First, this growth defect is not the result of abnormal germination, the process by which the spore transitions to mitotic cycling, because this slow-growth phenotype is maintained even when postspore cells are streaked onto a fresh YPD plate ([Figure 1A](#F1){ref-type="fig"}, bottom). Second, the poor growth of a *met4Δ* mutant was not due to insufficient import of exogenous methionine, because overexpression of the methionine transporters did not rescue this phenotype (Supplemental Figure S1). Third, the slow growth is not due to the absence of aerobic respiration, which requires sulfur metabolism ([@B5]), because *met4Δ* can grow on a nonfermentable carbon source (glycerol/ethanol) (Supplemental Figure S2).

The *MET4* gene is only 334 base pairs upstream of the essential *POL1* gene ([Figure 1B](#F1){ref-type="fig"}), so we were concerned that the slow growth of a *MET4*-deletion mutant actually resulted from a perturbation of *POL1*. To rule out this possibility, we complemented *met4Δ* with a plasmid containing only the *MET4* gene ([Figure 1C](#F1){ref-type="fig"}). This plasmid did indeed allow *met4Δ* cells to grow like wild type, whereas a control plasmid lacking *MET4* had no effect on *met4Δ* slow growth. These results indicated that it was the loss of *MET4*, and not loss of *POL1* or other genes, that was responsible for the growth defect. The plasmid that we used contains the selectable gene *URA3*, so we attempted to select for loss of the plasmid by growing cells on 5-fluoroorotic acid (5-FOA), a drug that kills *URA3*-expressing cells. However, we found that *met4Δ* cells with a *MET4* plasmid did not grow at all on 5-FOA because *met4Δ* cells alone do not grow on 5-FOA, even after extended incubation periods (Supplemental Figure S3).

The growth defect of *met4Δ* can be spontaneously suppressed
------------------------------------------------------------

When *met4Δ* cells from an overnight liquid culture in YPD are plated, they give rise to a mixture of small and large colonies ([Figure 1D](#F1){ref-type="fig"}). The size of the small colonies is similar to that of the previously observed *met4Δ* colonies. The size of the larger colonies is similar to that of wild-type colonies, suggesting that the *met4Δ* growth phenotype has been effectively suppressed. This large size is maintained when cells from a large colony are streaked onto fresh YPD plates, indicating that large colony size is mitotically stable (Supplemental Figure S4A). These cells remain methionine auxotrophs, separating the role of Met4p in methionine biosynthesis from its role in controlling cell growth. In addition, we found that this suppression phenotype is meiotically inherited by a mutation in an unlinked gene (Supplemental Figure S4B). To show this, the suppressed *met4Δ* strain was crossed to a *MET4* strain and the resulting diploid was dissected. Half of the *met4Δ* spores produced small colonies and half produced wild type--sized colonies, as would be expected if the suppression were the result of a mutation in a single gene unlinked to *MET4*.

Identifying mutations that suppress the growth defect of *met4Δ*
----------------------------------------------------------------

To identify the gene(s) in which suppressor mutations arise, we isolated such suppressors from 24 independent cultures, each of which was started by a *met4Δ* mutant (small colony) from tetrad dissection of a heterozygous diploid, as in [Figure 1D](#F1){ref-type="fig"}. In each case, large colonies were present at a high frequency, and we selected one of these colonies from each independent culture for further analysis. We performed initial complementation testing and found that these 24 mutants fell into several complementation groups, suggesting that suppression can be caused by a mutation in any of several different genes. To find potential causative mutations, we hybridized genomic DNA from several *met4Δ* suppressor mutants and their parental *MET4* strains to whole-genome tiling arrays and then used a computer program (SNPScanner) ([@B17]) to compare the genome sequence of each mutant to its parent. In this way, we found single-nucleotide polymorphisms (SNPs) in one of three genes: *OPI1*, *TUP1*, or *DOT6*. Then we sequenced the entire *OPI1*, *TUP1*, and *DOT6* open reading frames in all 24 strains and found that nine strains contained potential mutations in *OPI1*, 2 had potential mutations in *TUP1*, and 1 had a potential mutation in *DOT6* ([Table 2](#T2){ref-type="table"}). Two additional strains (DBY12223 and DBY12222 in [Table 3](#T3){ref-type="table"} later in the paper) have genomic rearrangements at *OPI1* that should produce an *opi1* loss-of-function mutant phenotype. Finally, there were 10 strains in which no mutations were observed, possibly because either 1) the strains contained *OPI1*, *TUP1*, or *DOT6* mutations (e.g., genomic rearrangements) that could not be detected by our analysis, or 2) the strains have mutations in other genes. Genetic analysis (see later discussion) confirmed that the *OPI1* and *TUP1* mutations are indeed causal; the *DOT6* SNP was not studied further.

###### 

Identity of the *met4Δ* suppressor mutations.

  Nucleotide mutation^a^   Amino acid change
  ------------------------ -------------------
  ***OPI1***               
  G376T^b^                 E126amber
  A409T                    K137amber
  G565T                    E189amber
  C614G                    S205umber
  A676G                    K226E
  T764C                    L255S
  C859T                    Q287amber
  C907T                    Q303ochre
  ***TUP1***               
  C2091G                   S697R
  G2095T                   D699Y
  ***DOT6***               
  C293A                    S98amber

^a^Relative to beginning of open reading frame.

^b^Observed in two suppressor mutants.

###### 

Strains used in this study.

  Name       Genotype                                                                                                                               Reference
  ---------- -------------------------------------------------------------------------------------------------------------------------------------- -------------------------
  FY4        MATa                                                                                                                                   [@B63]
  FY5        MATa                                                                                                                                   [@B63]
  DBY11250   MATa/a                                                                                                                                 This study
  DBY12000   MATa *HAP1*^+^                                                                                                                         [@B19]
  DBY12001   MATa *HAP1*^+^                                                                                                                         [@B19]
  DBY12007   MATa/a *HAP1*^+^/*HAP1*^+^                                                                                                             [@B19]
  DBY12042   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::KanMX/*MET4*                                                                                        This study
  DBY12043   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::NatMX/*MET4*                                                                                        This study
  DBY12210   MATa/a *HAP1*^+^/*HAP1*^+^*ura3Δ0*/*ura3Δ0 met4Δ::KanMX*/*MET4* pRS416+*MET4*                                                          This study
  DBY12211   MATa/a *HAP1*^+^/*HAP1*^+^*ura3Δ0*/*ura3Δ0 met4Δ::KanMX*/*MET4* pRS416                                                                 This study
  DBY12212   MATa/a *HAP1*^+^/*HAP1*^+^*ura3Δ0*/*ura3Δ0 met4Δ::KanMX*/*MET4*                                                                        This study
  DBY12213   MATa *HAP1*^+^*met4Δ*::KanMX                                                                                                           This study
  DBY12214   MATa *HAP1*^+^*met4Δ*::NatMX                                                                                                           This study
  DBY12215   MATa *HAP1*^+^*met4Δ*::KanMX *opi1-G376T*^a^                                                                                           This study
  DBY12216   MATa *HAP1*^+^*met4Δ*::NatMX *opi1-A409T*^a^                                                                                           This study
  DBY12217   MATa *HAP1*^+^*met4Δ*::KanMX *opi1-G565T*^a^                                                                                           This study
  DBY11402   MAT? *hap1*^−^*met4Δ*::NatMX *opi1-C614G*^a^                                                                                           This study
  DBY12218   MATa *HAP1*^+^*met4Δ*::KanMX *opi1-A676G*^a^                                                                                           This study
  DBY12219   MATa *HAP1*^+^*met4Δ*::NatMX *opi1-T764C*^a^                                                                                           This study
  DBY12220   MATa *HAP1*^+^*met4Δ*::NatMX *opi1-C859T*^a^                                                                                           This study
  DBY12221   MATa *HAP1*^+^*met4Δ*::NatMX *opi1-C907T*^a^                                                                                           This study
  DBY12222   MAT *HAP1*^+^*met4Δ*::NatMX *opi1*^b^                                                                                                  This study
  DBY12223   MAT *HAP1*^+^*met4Δ*::KanMX *opi1*^b^                                                                                                  This study
  DBY12224   MATa *HAP1*^+^*met4Δ*::NatMX *tup1-C2091G*^a^                                                                                          This study
  DBY11405   MATa *hap1*^−^*met4Δ*::NatMX *tup1-G2095T*^a^                                                                                          This study
  DBY11406   MATa *hap1*^−^*met4Δ*::NatMX *dot6-C293A*^a^                                                                                           This study
  DBY12225   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::KanMX/*MET4 opi1Δ*:: NatMX/*OPI1*                                                                   This study
  DBY12226   MATa *HAP1*^+^*met4Δ*:: NatMX *opi1Δ*::KanMX                                                                                           This study
  DBY12227   MAT a *HAP1*^+^*met4Δ*:: NatMX *opi1Δ*::KanMX                                                                                          This study
  DBY12228   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::NatMX/*MET4* KanMX::*GAL1*~pr~-*INO1*/*INO1*                                                        This study
  DBY12229   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::KanMX/*MET4 opi1Δ*::NatMX/*OPI1 ino1Δ*::HphMX4/*INO1*                                               This study
  DBY12230   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::NatMX/*MET4* KanMX::*GAL1*~pr~-*MUP1*/*MUP1*                                                        This study
  DBY12231   MATa/a *HAP1*^+^/*HAP1 met4Δ*::NatMX/*MET4* KanMX::*GAL1*~pr~-*MUP3*/*MUP3*                                                            This study
  DBY12232   MATa/a *HAP1*^+^/*HAP1*^+^*met4Δ*::KanMX/*MET4 tup1Δ*::NatMX/*TUP1*                                                                    This study
  DBY12233   MATa/a *HAP1*^+^/*HAP1 met4Δ*::NatMX/*MET4* KanMX::*GAL1*~pr~-*SAM2*/*SAM2*                                                            This study
  DBY12049   MATa *HAP1 gal1Δ*::*GAL1*~pr~-TEV::HphMX4 *leu2Δ0*::*ACT1*~pr~-GEV::NatMX *gal4Δ*::*LEU2*                                              McIsaac *et al*. (2011)
  DBY12055   MATa *HAP1 gal1Δ*::*GAL1*~pr~-TEV::HphMX4 *leu2Δ0*::*ACT1*~pr~-GEV::NatMX *gal4Δ*::*LEU2 NDeg*-*MET4*-*13Xmyc*::KanMX                  McIsaac *et al*. (2011)
  DBY12074   MATa *HAP1 gal1Δ*::*GAL1*~pr~-TEV::HphMX4 *leu2Δ0*::*ACT1*~pr~-GEV::NatMX *gal4Δ*::*LEU2 NDeg*-*MET4*-*13Xmyc*::KanMX *opi1Δ*::KanMX   This study
  CC849-8A   MATa *ade2-1 his3-1,15 leu2-3112 trp1-1 ura3 met4Δ*::*TRP1*                                                                            [@B44]^c,d^
  CC849-1B   MATa *ade2-1 his3-1,15 leu2-3112 trp1-1 ura3 met4Δ*::*TRP1*                                                                            [@B4]^c^
  yMT-234    MATa *ade2-1 can1-100 his3-1,15 leu2-3112 trp1-1 ura3*                                                                                 K. Nasmyth^c^

^a^Refers to the nucleotide change relative to the ATG.

^b^The exact *opi1* mutation is not known, but sequencing evidence suggests that there is a genomic arrangement.

^c^These strains are in the W303 genetic background.

^d^We found that this strain is MATa, in contrast to the reported MAT ([@B44]).

Mutations in *TUP1* suppress the growth defect of *met4Δ*
---------------------------------------------------------

Two SNPs in the *TUP1* open reading frame were found to potentially suppress the *met4Δ* growth defect ([Table 2](#T2){ref-type="table"}). These SNPs resulted in two amino acid changes that were very close together, as shown in the domain structure of the Tup1 protein ([Figure 2A](#F2){ref-type="fig"}). Tup1 is a general transcriptional corepressor that represses many genes in yeast and is recruited to DNA by transcription factors ([@B34]). Of note, the mutations that we isolated specifically affect a surface of a WD40 propeller blade that interacts with MAT2 and possibly other transcription factors ([@B23]; [@B50]), suggesting that disruption of Tup1 binding to transcription factors like Opi1p (discussed later) might be responsible for *met4Δ* growth suppression. To test whether deleting *TUP1* suppresses the poor growth of *met4Δ*, we created a diploid strain that was heterozygous for both *met4Δ* and *tup1Δ* ([Figure 2B](#F2){ref-type="fig"}). Then this diploid was sporulated and dissected on YPD plates, creating spores with all combinations of deletions. As has been widely observed, we found that a *tup1Δ* strain grew slower than did the wild type. Nonetheless, a *met4Δ tup1Δ* strain grew better than a *met4Δ* strain, indicating that *tup1Δ* suppresses the *met4Δ* growth defect.

![Mutations in *TUP1* suppress the growth defect of *met4Δ.* (A) We found two *met4Δ-*suppressed strains with mutations in the *TUP1* gene ([Table 2](#T2){ref-type="table"}). The mutations (S697R and D699Y) are depicted in relation to the encoded Tup1p protein and its previously determined domains ([@B23]), and they are in a region of the protein that affects Tup1p interaction with transcription factors ([@B50]). (B) Deletion of *TUP1* causes a *met4Δ* haploid to grow significantly better. A *met4Δ*/*MET4 tup1Δ*/*TUP1* diploid (DBY12232) was sporulated, and the resulting tetrads were dissected on YPD plates. The *met4Δ tup1Δ* cells remained methionine auxotrophs.](4192fig2){#F2}

Deleting *OPI1* suppresses the growth defect of *met4Δ*
-------------------------------------------------------

The mutations in the *OPI1* gene ([Table 2](#T2){ref-type="table"}) were overlaid on the domain structure of the Opi1p protein ([Figure 3A](#F3){ref-type="fig"}). This map shows that a variety of mutations, including severe mutations that prevent expression of the C-terminal two-thirds of Opi1p, potentially suppress the *met4Δ* growth defect. This suggested that loss of Opi1p function may suppress the *met4Δ* phenotype and led us to test whether an *opi1Δ* allele deletion also suppresses the *met4Δ* phenotype. First, we created a diploid strain that was heterozygous for both *opi1Δ* and *met4Δ* ([Figure 3B](#F3){ref-type="fig"}). Then this diploid was sporulated and dissected on YPD plates, creating spores with all combinations of deletions. As expected, we observed that *opi1Δ* suppressed the *met4Δ* growth defect. As a control, *opi1Δ* did not affect growth of an otherwise wild-type strain. To quantify the effect of *OPI1* on growth rate, we compared the doubling times of these strains in liquid YPD, which confirmed that *met4Δ* grows more slowly (i.e., has a greater doubling time) than either *MET4* or *met4Δ opi1Δ* ([Figure 3C](#F3){ref-type="fig"}). The *opi1Δ* allele acted recessively, as expected, because crossing a *met4Δ opi1Δ* strain to a *met4Δ* strain resulted in slow-growing diploids ([Figure 3D](#F3){ref-type="fig"}, top). As a control, crossing a *met4Δ opi1Δ* strain to a *met4Δ opi1Δ* strain resulted in normally growing diploids ([Figure 3D](#F3){ref-type="fig"}, bottom).

![Opi1p is required for the slow growth of *met4Δ* cells. (A) The mutations in the *OPI1* gene are depicted in relation to the encoded Opi1p protein and its previously determined domains ([@B51]). The following structural and functional domains are depicted: Sin3 (Sin3-interacting), LZ (leucine zipper), and QQQ (glutamine rich). Protein kinase A phosphorylates residues Ser-31 and Ser-251, whereas protein kinase C phosphorylates Ser-26. (B) Deletion of *OPI1* causes a *met4Δ* haploid to grow like wild type. A *met4Δ*/*MET4 opi1Δ*/*OPI1* diploid (DBY12225) was sporulated, and the resulting tetrads were dissected on YPD plates. The tetrads showed the 2:2, 3:1, and 4:0 large:small patterns as expected. The *met4Δ opi1Δ* cells remained methionine auxotrophs. (C) The doubling time of *met4Δ* is higher than that for *MET4* or *met4Δ opi1Δ*. The *MET4* (DBY12000), *met4Δ* (DBY12214), and *met4Δ opi1Δ* (DBY12226) strains were inoculated into YPD at low density and the cell concentration was followed until they reached saturation. The exponential phase of growth was used to calculate the doubling time only for cultures that did not develop growth suppression. A representative graph from many experiments is shown. (D) The *opi1Δ* allele acts recessively to suppress the growth defect of a *met4Δ* strain. Top, a *met4Δ* haploid (DBY12214) was crossed to a *met4Δ opi1Δ* haploid (DBY12227), and the resulting *met4Δ*/*met4Δ opi1Δ*/*OPI1* diploids (three are shown) were grown for 2 d. Bottom, a *met4Δ opi1Δ* haploid (DBY12227) was crossed to a *met4Δ opi1Δ* haploid (DBY12226), and the resulting *met4Δ*/*met4Δ opi1Δ*/*opi1Δ* diploids (three are shown) were grown for 2 d.](4192fig3){#F3}

Simultaneously studying transcriptional regulation by Met4p and Opi1p
---------------------------------------------------------------------

We further investigated the genetic interaction between Opi1p and Met4p because, in addition to the results presented earlier, we previously found that the expression of two Opi1p targets (*OPI3* and *CKI1*) depends specifically on methionine and sulfur abundance ([@B42]). Given that both Opi1p and Met4p are transcriptional regulators, we sought to understand their genetic interaction from a transcriptional perspective. Because a *met4Δ* strain readily develops growth suppressor mutations, we studied Met4p transcriptional regulation using a system in which Met4p can be quickly degraded by an estradiol-inducible TEV protease (McIsaac *et al*., 2011). Such a system is indispensable for studying unstable deletion phenotypes like that of *met4Δ*, because the target protein (in this case, Met4p) is degraded with a half-life of ∼15 min, well before suppressor mutations can arise. We used the *NDeg-MET4* strain containing the machinery necessary for estradiol induction, an inducible TEV protease gene, and the *MET4* gene N-terminally tagged with a TEV protease site. To simultaneously study Opi1p transcriptional regulation, we used a pair of strains: 1) *NDeg-MET4*, in which *OPI1* is wild type, and 2) *opi1Δ NDeg-MET4*. We also included a control strain that contains the estradiol-induction machinery and inducible TEV protease gene but wild-type *MET4* and *OPI1* genes.

To compare gene expression across these strains, we grew each to midexponential phase in minimal medium, added estradiol, and measured mRNA abundance at several time points up to 6 h after estradiol addition (Supplemental Data Set S1). We focused our analysis on the immediate response observed within 30 min after estradiol addition (*Materials and Methods*). Confirming that Met4p is degraded, we found that the canonical Met4p targets ([@B27]) are indeed turned off after estradiol addition ([Figure 4](#F4){ref-type="fig"}). Many of these targets are slightly turned off in the control strain, but they are significantly more turned off in the *NDeg-MET4* strain (see [Figure 5](#F5){ref-type="fig"} and Supplemental Data Set S1). Furthermore, many of the targets known to be repressed by Opi1p ([@B46]) are derepressed in *opi1Δ NDeg-MET4* compared with *NDeg-MET4* ([Figure 4](#F4){ref-type="fig"}).

![Role of Met4p and Opi1p in regulating sulfur assimilation and PC biosynthesis pathways. Gene expression data for the biosynthesis genes were overlaid on the pathways. Gene expression time courses for a given gene are shown beneath that gene. Top and bottom, *NDeg-MET4* and *opi1Δ NDeg-MET4*, respectively, with log~2~ fold change as indicated in the legend. Gene expression time courses are displayed as in the legend: from the instant before 1 μM estradiol treatment (0′) until 30 min after treatment (30′). Values at 0, 5, 15, and 30 min represent actual experimental measurements (indicated with black boxes above the time course), whereas values at 10, 20, and 25 min represent interpolated values (indicated with gray boxes above the time course) (see *Materials and Methods*). Genes directly regulated by Met4p ([@B27]) are shown in blue; genes directly regulated by Opi1p ([@B46]) are shown in green; joint targets are shown in red. CDP-choline, cytidine diphosphate choline; CDP-DG, cytidine diphosphate diacylglycerol; APS, 5′-adenylylsulfate; G6P, glucose 6-phosphate; Hcy, homocysteine; I3P, inositol 3-phosphate; Met, methionine; P-choline, phosphocholine; PA, phosphatidic acid; PAPS, 3′-phospho-5′adenylylsulfate; PC, phosphatidylcholine; PDME, phosphatidyl-dimethylethanolamine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PME, phosphatidyl-monomethyl-ethanolamine; PS, phosphatidylserine; S^2−^, sulfide; SAM, *S*-adenosylmethionine; SO~3~^2−^, sulfite; SO~4~^2−^, sulfate; THF, tetrahydrofolate.](4192fig4){#F4}

![Genome-wide expression analysis of Met4p and Opi1p regulation. Multiple regression was used to identify genes whose expression is primarily dependent on Met4p abundance (A), Opi1p abundance (B), or both (C). Three strains (the control strain, *NDeg-MET4*, and *opi1Δ NDeg-MET4*) were treated with 1 μM estradiol. Gene expression is shown from the instant before estradiol treatment (0′) until 30 min after treatment (30′), with log~2~ fold change as indicated in the legend. Values at 0, 5, 15, and 30 min represent actual experimental measurements (indicated with black, red, or dark green boxes above the time courses, respectively), whereas values at 10, 20, and 25 min represent interpolated values (indicated with gray, pink, or light green boxes above the time courses, respectively; see *Materials and Methods*). Only genes that change by a factor of at least 1.5 in at least one time course are shown. Gene names discussed in the text are shown in the figure. Previously identified targets of Met4p are indicated with green ([@B27]) or blue ([@B32]). Previously identified targets of Opi1p are indicated with red ([@B46]) or yellow ([@B32]) dots.](4192fig5){#F5}

In an initial, semiquantitative comparison of *NDeg-MET4* and *opi1Δ NDeg-MET4*, we found that *INO1* exhibited the most striking difference between the strains ([Figures 4](#F4){ref-type="fig"} and [5B](#F5){ref-type="fig"}). *INO1,* a gene required for inositol biosynthesis, is the best-described target of Opi1p ([@B62]). It is also a target of Cbf1, a DNA-binding partner of Met4p ([@B47]). Even before estradiol addition, the *INO1* transcript is ∼32 times more abundant in *opi1Δ NDeg-MET4* than in the other strains*. INO1* expression increases over time in all three strains (including the control), reaching a final abundance in *opi1Δ NDeg-MET4* that is 23 times greater than in *NDeg-MET4* and 9 times greater than in the control.

Deleting or manipulating expression of *INO1* has no effect on the growth of either *met4Δ* or *met4Δ opi1Δ* strains
--------------------------------------------------------------------------------------------------------------------

To test whether the slow growth phenotype of *met4Δ* is due to *INO1* misregulation, we made a *met4Δ*/*MET4 GAL1*~pr~-*INO1*/*INO1* diploid strain, sporulated it and dissected the spores on yeast extract/peptone (YP) media either with glucose or galactose as a carbon source (to turn off or on *INO1* expression, respectively). We found that repression or overexpression of *INO1* had no effect on *met4Δ* growth (Supplemental Figure S5A). Next we wanted to know whether the normal growth of *met4Δ opi1Δ* was due to a change in *INO1* expression. We therefore made a *met4Δ*/*MET4 opi1Δ*/*OPI1 ino1Δ*/*INO1* diploid strain, sporulated it, and dissected the spores on YPD media. Deleting *INO1* had no effect on the growth of any strains, including a *met4Δ* mutant and a *met4Δ opi1Δ* mutant (Supplemental Figure S5B). These data show that *INO1* is not involved in the regulation of growth by Met4p and Opi1p.

Gene expression analysis suggests that Met4p and Opi1p both regulate SAM levels
-------------------------------------------------------------------------------

Next we searched for other gene expression differences that might explain the role of Met4p and Opi1p in growth regulation. We began by using multiple regression to quantify the dependence of each gene in the original data set on Met4p and Opi1p (see *Materials and Methods* for data processing and filtering). This analysis identified most of the known Met4p and Opi1p target genes ([@B46]; [@B27]), as well as other genes that may either be indirectly regulated or newly identified targets ([Figure 5](#F5){ref-type="fig"}). All of these genes can be grouped into three categories: 1) 75 genes affected only by Met4p abundance ([Figure 5A](#F5){ref-type="fig"}), 2) 65 genes affected only by Opi1p abundance ([Figure 5B](#F5){ref-type="fig"}), and 3) 43 genes affected by both Met4p and Opi1p ([Figure 5C](#F5){ref-type="fig"}). This coregulation by Met4p and Opi1p is statistically significant (p \< 0.0001), suggesting that the biochemical processes regulated by Met4p (sulfur assimilation) and Opi1p (phospholipid biosynthesis) are interdependent. However, almost all coregulation by Met4p and Opi1p is carried out by indirect or nontranscriptional mechanisms, because only one gene, *SAM2,* has been shown to be regulated by both Met4p and Opi1p ([@B46]; [@B27]). The *SAM2* gene will be discussed later.

To further understand how Opi1p specifically affects growth of a *met4Δ* strain, we analyzed the 108 genes that are Opi1p regulated (i.e., differentially expressed between *opi1Δ NDeg-MET4* and *NDeg-MET4*; false-discovery rate \[FDR\] \< 0.1; [Figure 5, B](#F5){ref-type="fig"} and [C](#F5){ref-type="fig"}). This set is highly enriched for genes whose products 1) associate with the cellular membrane and 2) function in cation homeostasis, oxidation--reduction, sulfur assimilation, the trichloracetic acid cycle, carbohydrate metabolism, and transmembrane transport (Supplemental Data Set S2). Notably, this set also contains three of the five genes that regulate intracellular SAM abundance: the two SAM synthetase genes (*SAM1* and *SAM2*) and the SAM transporter gene (*SAM3*; p = 0.0016 by hypergeometric distribution). From this analysis, we speculated that deleting *OPI1* suppresses the growth defect of a *met4Δ* strain by affecting one or more of these Opi1p-regulated processes.

Inspection of the metabolic pathways governing phospholipid biosynthesis reveals that PC biosynthesis, which is repressed by Opi1p, requires SAM at three steps ([Figure 4](#F4){ref-type="fig"}; [@B12]). We overlaid gene expression data on the metabolic pathways regulated by Met4p and Opi1p and found that several SAM biosynthesis genes are activated by Met4p and repressed by Opi1p. Most notably, *SAM2* is weakly activated by Met4 and strongly repressed by Opi1 (p = 9.4 × 10^−3^ based on use of the F test to compare *opi1Δ NDeg-MET4* and *NDeg-MET4*; see *Materials and Methods*). Average *SAM2* abundance, which changes little in response to estradiol, is 5.5 times higher in *opi1Δ NDeg-MET4* than in *NDeg-MET4* (p = 0.038 by Student\'s *t* test)*. SAM3* behaves similarly (p = 0.003 by the F test); on average, *SAM3* abundance is 12 times higher in *opi1Δ NDeg-MET4* than in *NDeg-MET4* (p = 0.078 by Student\'s *t* test). Although *SAM1* follows a similar pattern, it is only weakly repressed by *OPI1*: during the first 30 min after estradiol addition, *SAM1* abundance falls nearly fourfold in *NDeg-MET4* and 2.1-fold in *opi1Δ NDeg-MET4*. Thus the interdependence of Met4p- and Opi1p-regulated pathways may be based on SAM metabolism. In previous work, we found that SAM is rapidly and dramatically depleted in methionine auxotrophs ([@B42]). We therefore hypothesized that *met4Δ* mutants grow slowly because they lack sufficient SAM for PC biosynthesis.

Increased amounts of SAM suppress the growth defect of *met4Δ*
--------------------------------------------------------------

SAM is required for growth and can be either synthesized endogenously by Sam1p or Sam2p or added exogenously to a SAM auxotroph. However, SAM is not present in YPD because it is a highly unstable metabolite and thus likely does not survive the autoclaving process ([@B25]). Therefore we predicted that *met4Δ* cells grow slowly because they are unable to express the Met4p-regulated *SAM2* gene and thus synthesize SAM. To test this, we first sporulated a *met4Δ*/*MET4* heterozygote and dissected the spores on YPD with freshly added SAM ([Figure 6A](#F6){ref-type="fig"}). Indeed, we found that a *met4Δ* spore grew almost as well as a wild-type spore under these conditions. Next we created a *met4Δ*/*MET4 GAL1*~pr~-*SAM2*/*SAM2* diploid strain, sporulated it, and dissected spores on YP media either with glucose or galactose as a carbon source (to turn off or on *SAM2* expression, respectively) ([Figure 6B](#F6){ref-type="fig"}). As expected, a *met4Δ GAL1*~pr~-*SAM2* spore grew like wild type on galactose (when overexpressing *SAM2*) and poorly on glucose (with *SAM2* turned off). Thus the poor growth of *met4Δ* cells can be suppressed by increasing the intracellular concentration of SAM.

![Increasing intracellular levels of SAM suppresses the growth defect of *met4Δ.* (A) Adding SAM to YPD rescues growth of a *met4Δ* haploid. A *met4Δ*/*MET4* heterozygote (DBY12043) was sporulated, and the resulting tetrads were dissected on YPD plates with 0.2 mM SAM. Many SAM concentrations (0.05--0.5 mM) were tested, with 0.2 mM supporting the optimal *met4Δ* growth. The *met4Δ* cells remained, as expected, methionine auxotrophs. (B) Overexpression of the *SAM2* gene rescues growth of a *met4Δ* haploid. A *met4Δ*/*MET4 GAL1*~pr~-SAM2/*SAM2* heterozygote (DBY12233) was sporulated, and the resulting tetrads were dissected on YPD or YPGal plates.](4192fig6){#F6}

Expression data suggest that Met4p and Opi1p both indirectly affect membrane function
-------------------------------------------------------------------------------------

The Met4p-dependent genes that we identified earlier have a wide variety of cellular functions (Supplemental Data Set S2). One group of genes, those repressed by Met4p (i.e., induced during Met4p degradation), is enriched for iron homeostasis genes (*FTR1, SMF3, COT1, MRS4, FET3, FRE1*; [Figure 5A](#F5){ref-type="fig"}; FDR \< 0.1). These genes were derepressed even before estradiol was added to the *NDeg-MET4* strain, suggesting that Met4p may be slightly unstable in this strain due to modification and that these genes are very sensitive to the levels of Met4p. Consistent with these data, we previously observed dramatic induction of the same iron homeostasis genes upon deletion of *MET31* and *MET32* ([@B42]).

We found that these and additional iron homeostasis genes *(FRE3, FRE2, FIT2, SIT1, ARN1, FIT3, MSC2, ARN2, ENB1*) are also activated by Opi1p (i.e., less strongly induced by Met4p degradation in *opi1Δ NDeg-MET4* than in *NDeg-MET4*; [Figure 5C](#F5){ref-type="fig"}). Surprisingly, none of these genes is a known direct target of Met4p or Opi1p (or Met31/Met32/Cbf1; [Figure 5, A--C](#F5){ref-type="fig"}), indicating that Met4p and Opi1p affect iron homeostasis by indirect regulation of expression. Of note, all of the proteins encoded by these genes are physically located in or at the cellular membrane, suggesting the following hypothetical chain of regulatory events: Met4p degradation leads to a drop in SAM levels and a subsequent decrease in PC biosynthesis. This PC decrease perturbs a wide variety of processes, such as iron homeostasis, that depend on cellular membranes for transport and intracellular homeostasis. Deleting *OPI1* bypasses the decrease in PC biosynthesis, alleviating the perturbation in iron homeostasis.

The *met4Δ* slow-growth phenotype occurs in the W303 strain background
----------------------------------------------------------------------

We found that deleting *MET4* in the S288C genetic background causes slow growth. We wanted to test whether this is the case in another background, W303, which has been used extensively in studying Met4p ([Table 1](#T1){ref-type="table"}). We found that two previously generated *met4Δ* strains have frameshift *opi1* mutations that allow them to grow normally. On crossing these strains to a wild-type strain and sporulating the diploid, we found that half of the resulting *met4Δ* spores grew slowly (no suppression) and the other half grew normally (suppressed). The *met4Δ* slow growth can be rescued by adding SAM to the media (Supplemental Figure S6).

DISCUSSION
==========

Met4p has long been known to regulate the genes of the sulfur assimilation pathway, which is responsible for the incorporation of extracellular sulfate into methionine, cysteine, homocysteine, and SAM. Indeed, Met4p was previously shown to be required for methionine biosynthesis ([@B35]). We show here that Met4p also contributes to the biosynthesis of SAM, an essential metabolite that serves as the methyl donor in most methyltransferase reactions ([@B58]). Specifically, we found that SAM must be added to YPD in order for *met4Δ* cells to grow at wild-type rates, indicating that *met4Δ* is not only a methionine auxotroph but also a partial SAM auxotroph even in the presence of excess methionine, either provided in the medium or by overexpression of a methionine transporter. However, *met4Δ* cells are able to grow, albeit slowly, on YPD, indicating that *met4Δ* cells either carry out limited SAM biosynthesis from methionine or import some SAM from rich media.

The increased SAM requirement of *met4Δ* is consistent with the known role of Met4p in regulating the expression of genes required for SAM biosynthesis, specifically the biosynthetic *MET* and *SAM* genes ([@B57]; [@B56]; [@B44]; [@B27]). These genes are directly induced by Met4p ([@B27]), consistent with our microarray analysis showing that expression of these genes decreases upon Met4p degradation ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} and Supplemental Data Set S1). In addition, Met4p degradation decreases the expression of *FOL1*, encoding an enzyme in the folate metabolism pathway that contributes a methyl group in the conversion of homocysteine to methionine.

The *met4Δ* growth defect can be suppressed by increasing endogenous SAM levels, as described earlier, or by spontaneous loss-of-function mutations in a variety of genes, including *OPI1* and *TUP1*. Independently deleting *OPI1* or *TUP1* in a *met4Δ* strain recapitulated the effects of these mutations. Our expression microarray analysis showed that Opi1p represses *SAM2* expression, whereas Met4p induces *SAM2*, consistent with previous results ([@B22]; [@B46]; [@B20]). This suggests that *opi1Δ* suppresses *met4Δ* slow growth by derepressing *SAM2* and thereby increasing SAM levels. Indeed, overexpression of *SAM2* is sufficient to suppress the growth defect of a *met4Δ* strain. The ability of a *tup1Δ* allele to suppress the *met4Δ* growth defect may also lie in its ability to compensate for the SAM deficiency of *met4Δ*. This is because Tup1, like Opi1p, represses *SAM2*, as Tup1 is required for repression of Opi1p-regulated genes ([@B60]).

Our experiments suggest that derepression of *SAM2* is the main mechanism of suppressing the *met4Δ* growth defect, but Opi1p inactivation might compensate for the SAM deficiency through four alternative mechanisms. First, an *opi1* mutation derepresses all of the PC biosynthetic genes (*CDS1*, *CHO1*, *PSD1*, *CHO2*, and *OPI3*), thereby increasing flux through the pathway. If PC is the major consumer of SAM, as we argue later, this may allow cells to produce sufficient PC when SAM levels are low. Second, an *opi1* mutation derepresses expression of *CKI1*, required for the Kennedy pathway that produces PC without SAM. However, this pathway uses choline obtained from the breakdown of PC and thus cannot be used for de novo PC biosynthesis. Third, an *opi1* mutation derepresses methionine biosynthetic genes, presumably leading to increased production of methionine and SAM. Fourth, an *opi1* mutation derepresses the *FOL1* gene, a component of the folate cycle that donates a methyl group for methionine biosynthesis. The result could be increased levels of methionine and subsequently SAM.

Our results point to transcriptional and metabolic coordination between the sulfur assimilation pathway, regulated by Met4p, and the PC biosynthetic pathway, regulated by Opi1p. Previous work implied that these pathways are connected through SAM-dependent methylation ([@B46]; [@B33]; [@B42]). Here we show that Opi1p and Met4p genetically interact because they both contribute to regulating SAM levels. The sulfur assimilation pathway is required for the biosynthesis of SAM, which provides a methyl group during three steps in PC biosynthesis ([Figure 4](#F4){ref-type="fig"}). Opi1p directly represses *SAM2* expression as well as PC biosynthetic genes, likely to maintain coordination of SAM levels with the SAM requirement of PC biosynthesis. Our search of the *SAM2* literature and for potential binding sites in the *SAM2* promoter shows that, besides the Met4p transcriptional complex, Opi1p is the only known direct regulator of *SAM2.* From this finding, we hypothesize that PC biosynthesis accounts for the majority of SAM-dependent methylation reactions, although this remains to be tested. Phospholipids represent a major portion of the dry weight of a yeast cell ([@B40]; [@B53]), with PC making up at least 30% of phospholipids ([@B53]). As shown in [Figure 4](#F4){ref-type="fig"}, PC is biosynthesized de novo from another phospholipid, phosphatidylethanolamine (PE), in three SAM-consuming methyltransferase reactions catalyzed by Opi3 and Cho2 ([@B12]; [@B54]; [@B37]; [@B22]). In contrast, ergosterol, another membrane lipid synthesized by SAM-dependent methylation, may be as abundant as PC ([@B40]), but the synthesis of one ergosterol molecule only consumes one SAM ([@B36]). Thus the SAM requirement is three times higher to make PC than to make ergosterol. Although SAM is used in several other reactions, such as during the biosynthesis of biotin and polyamine and in the modification of RNA and proteins ([@B58]), these reactions are likely not significant consumers of SAM because the products are at relatively low levels in comparison to the membrane lipids.

*OPI1* inactivation was the most common spontaneous mutation causing *met4Δ* suppression. We found that the mechanism of suppression is consistent with an increase in SAM levels, and *OPI1* inactivation is likely the simplest way to achieve this. Opi1p represses transcription by inhibiting the transcriptional activators Ino2 and Ino4, and therefore an *opi1Δ* mutant causes relative activation of Ino2/Ino4--dependent genes like *SAM2* ([@B46]; [@B20]; [@B11]). Because it is more likely that a mutation causes a loss of function (LOF) than a gain of function (GOF), increased *SAM2* expression is more likely to be caused by LOF *opi1* mutations than GOF mutations in *INO2*, *INO4*, the *SAM2* promoter, or other positive regulatory genes. There are other *SAM2* negative regulators, such as *TUP1*, that could be the target of LOF mutations. However, since *TUP1* itself is required for normal growth, few mutations in this gene will cause suppression without affecting growth. Indeed, the two *tup1* SNPs that we identified likely were this type of mutation because they were close together on the *TUP1* gene and resulted in growth that was better than that with *tup1Δ*.

Finally, our findings may be of clinical importance. It was previously shown that inhibiting the methylation steps of de novo PC biosynthesis, through deletion of *SAH1*, *OPI3*, or *CHO2*, leads to triacylglycerol accumulation, an indicator of several diseases, including heart disease ([@B33]). We found that SAM deficiency caused by *met4Δ* may also inhibit the PC pathway. Our work shows that inactivation of Opi1p might prevent this inhibition and the consequent accumulation of triacylglycerol. Although humans do not have an Opi1p orthologue, they may have a similar mechanism for sensing phospholipid levels ([@B30]). Thus targeting this mechanism could be a way to treat diseases of lipid accumulation. More generally, a more complete understanding of the regulatory relationships between metabolic pathways will be useful in understanding the etiology of metabolic diseases.

MATERIALS AND METHODS
=====================

Strains
-------

All *S. cerevisiae* strains are listed in [Table 3](#T3){ref-type="table"}, and almost all are isogenic with a *GAL2^+^* derivative of S288C containing a repaired *HAP1* allele ([@B63]; [@B19]). The rest of the strains are in the W303 background. Strains were constructed by standard methods, either by crosses or by transformation ([@B3]). The deletion alleles were created by replacing the respective open reading frame (ORF) with the *KanMX* or *NatMX* ([@B7]) or HphMX4 markers ([@B9]). The *KanMX::GAL1~pr~-ORF* alleles (where *ORF* = *SAM2*, *MUP1*, *MUP3*, or *INO1*) was constructed by placing the *KanMX* marker and the *GAL1* promoter upstream of the respective ORF ([@B31]). The selection drugs used were ClonNat (100 μg/ml; Werner BioAgents, Jena, Germany), G418 (100 μg/ml; Cellgro, Manassas, VA), and hygromycin (2900 U/ml; Calbiochem, La Jolla, CA).

Media and growth conditions
---------------------------

Cells were grown at 30°C in 1% yeast extract, 2% peptone, 2% glucose (YPD), unless otherwise noted. Yeast extract/peptone/galactose (YPGal) and YP + glycerol/ethanol contained 2% galactose and 2% of a 50/50 glycerol/ethanol mixture, respectively, in place of glucose. SAM (A7007; Sigma-Aldrich, St. Louis, MO) was made up in water at 20 mg/ml, filter sterilized, and added to YPD plates 1 d before plating cells. The *met4Δ* allele was maintained in a *met4Δ*/*MET4* heterozygous diploid to prevent suppressor formation; there was no haploinsufficiency or suppressor formation seen in this diploid. To create a *met4Δ* haploid with or without other mutations, the relevant diploid was sporulated by growing it to mid-log in YPD, washed in water, and grown in sporulation media (1% potassium acetate) for 3 d at room temperature. The resulting tetrads were dissected by dissection microscopy. As denoted in the figures, pictures were taken after 2 or more days of growth. In the figures, a representative tetrad may be shown, but at least 10 complete tetrads were analyzed for each diploid. The resulting spores were tested for all of the relevant marker phenotypes. All experiments in liquid media were plated upon completion to check for growth suppression of the *met4Δ* growth defect.

Mutation analysis
-----------------

Suppressor strains were colony purified by plating and then grown overnight in liquid YPD. Genomic DNA was isolated from saturated cultures using a Qiagen (Valencia, CA) Genomic DNA kit and prepared for hybridization to high-density, whole-genome tiling arrays (GeneChip *S. cerevisiae* Tiling 1.0R; Affymetrix, Santa Clara, CA), as described previously ([@B17]). The hybridization data were processed by the SNP Scanner program, which calculated the probability of a mutation at each nucleotide in the genome. These data were visualized using Integrated Genome Browser (<http://bioviz.org/igb/>) to determine mutations that were specific to *met4Δ* suppressor strains compared with a reference (FY4) and parental strains (DBY12000 and DBY12001).

Estradiol-induction mRNA abundance--time courses
------------------------------------------------

A single colony of *NDeg-MET4*, *opi1Δ NDeg-MET4*, or the control strain was grown to mid-log phase. Estradiol was added to a final concentration of 1 μM or 10 nM, and 5-ml aliquots of culture were filtered and flash-frozen in liquid nitrogen at 0 (immediately before estradiol addition), 5, 15, 30, 60, 120, 180, and 360 min after estradiol addition. RNA was isolated using standard phenol:chloroform extraction, purified using an RNeasy RNA purification kit (Qiagen), labeled using the QuickAmp labeling kit (Agilent, Santa Clara, CA), hybridized to 8 × 15k Yeast Aligent Oligo V2 microarrays using Agilent reagents and protocols, washed, and scanned as described ([@B8]).

Expression data analysis
------------------------

All expression data (for both 1 μM and 10 nM estradiol) are provided in Supplemental Data Set S1 and are available in the Princeton University MicroArray database (<http://puma.princeton.edu>). Expression data were processed as described ([@B42]) in order to select genes whose time dependence is statistically significant (p ≤ 0.05) and whose maximum fold change is at least 1.5 in any of the three strains. We also included genes with no time dependence if they showed constitutive differences in expression among the strains (analysis of variance q value ≤ 0.1; [@B52]). To focus our analysis on the most direct effects of Met4p degradation, we used data from the first 30 min (during which the known Met4p targets reached their maximum level of repression) in subsequent processing steps. We also measured gene expression in the same three strains using 10 nM estradiol. These data were used to check each gene for qualitative consistency across different doses of estradiol but were not used in quantitative analyses because other work in our lab showed that 1 µM estradiol is saturating for the estradiol-induction machinery (McIsaac *et al*., 2011). Genes meeting the foregoing criteria were hierarchically clustered using the MultiExperiment Viewer ([@B45]; Supplemental Figure S7) and used as a starting point for the analyses to be described.

Classification of transcription factor dependence
-------------------------------------------------

Multiple regression was used to determine whether each gene depends on Met4p, Opi1p, or both. *NDeg-MET4* was compared with the control using the regression model in Eq. 1A, and *opi1Δ NDeg-MET4* was compared with *NDeg-MET4* using the regression model in Eq. 1B. In Eq. 1A, the dummy variable D~M~ classifies the strain as an *NDeg-MET4* strain or a control strain (D~M~ = 1 for *NDeg-MET4*; D~M~ = 0 for control). In Eq. 1B, the dummy variable D~o~ classifies the strain as an *opi1Δ NDeg-MET4* strain or an *NDeg-MET4* strain (D~o~ = 1 for *opi1Δ NDeg-MET4*; D~o~ = 0 for *NDeg-MET4*). Regression significance was calculated from the F statistic comparing the fit of the full model (Eq. 1A or Eq. 1B) to the fit of the reduced model (Eq. 1C).

Regression model for dependence on Met4p:

Regression model for dependence on Opi1p:

Reduced regression model:

A gene was defined as uniquely Met4p dependent (or uniquely Opi1p dependent) if it 1) exhibited statistically significant strain specificity in 1A but not 1B (1B but not 1A), using the F-statistic q value as a measure of significance (q ≤ 0.1, p ≤ 0.033), or 2) exhibited constitutively different expression from the comparison strain, using the *t*-test q value as a measure of significance (q ≤ 0.1, p ≤ 0.0014). Because the expression profiles of some genes did not fit well to any quadratic, we also included a small number of genes whose expression differed between the strains by a factor of at least two at one or more time points, as long as expression pattern was consistent in both the 1 μM and 10 nM data sets. A gene was defined as jointly dependent on both Met4p and Opi1p if it exhibited strain specificity in both comparisons. We also analyzed genes that were Opi1p regulated but not uniquely so. (These exhibited statistically significant strain specificity in comparison 1B, without regard to comparison 1A.)

Accurately representing time-dependent data using heat maps
-----------------------------------------------------------

We introduce here a new method for representing unevenly sampled gene expression time-course data using heat maps. As in this study, it is common practice to sample biological time courses unevenly, such that measurements are taken more frequently when the variable of interest is changing most quickly. Although heat maps represent high-throughput expression data with unparalleled convenience and conciseness, they misrepresent the time dependence of unevenly sampled data. As a result, visual inspection of heat maps often leads to incorrect conclusions about expression dynamics. Scatterplots, on the other hand, represent time dependence accurately but are not amenable to high-throughput analysis and concise representation (e.g., of hierarchically clustered genes). We combined the best features of both graphical methods by linearly interpolating our unevenly sampled gene expression data and representing the interpolated data using a heat map. As a result, each pair of data points (either real or interpolated) is separated by the same time interval, and the dynamic changes in gene expression are displayed accurately. These interpolated values are only for display in [Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} and are not included in any of our statistical analyses.

Functional enrichment analysis
------------------------------

The functional enrichment of all gene clusters was measured with respect to the functional categorization of yeast genes in the Gene Ontology (<http://www.geneontology.org>; [@B2]). Enrichment for Gene Ontology terms was measured using the Generic Gene Ontology Term Finder ([@B6]) available at <http://go.princeton.edu/cgi-bin/GOTermFinder>. Here we used the FDR option for multiple hypothesis correction and only report enrichments with FDR ≤ 0.1. The results of these analyses are shown in Supplemental Data Set S2.
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